Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk Malignant Index”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableStudy completedNCT03404687
What this trial is testing

Risk of Malignancy Index and Assiut Scoring Model for Adnexal Malignancy

Who this might be right for
Risk Malignant Index
Assiut University 250
Not applicableStudy completedNCT01610531
What this trial is testing

COPARIME: Pilot Study of a Target Detection of Malignant Melanoma

Who this might be right for
Patients at Risk for Melanoma
Nantes University Hospital 4,118
Testing effectiveness (Phase 2)Looking for participantsNCT07523555
What this trial is testing

Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaRelapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLLRelapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia+4 more
Beijing Biotech 96
Not applicableUnknownNCT01764646
What this trial is testing

Hypofractionated Radiation Therapy in Prostate Cancer

Who this might be right for
Malignant Neoplasm of ProstateLocal Disease
Thomas Zilli 170
Not applicableUnknownNCT02847832
What this trial is testing

Prospective Validation and Comparison of Different Ultrasound Methods for Discrimination Between Benign and Malignant Ovarian/Tubal Masses Prior to Surgery

Who this might be right for
Patients With Adnexal Mass Prior to Surgery
KU Leuven 1,700